Founded in 2017 with the vision of transforming medicine through vanishingly-small implantable devices, iota (iota.bio) holds exclusive rights to the award-winning neural dust technology developed by researchers at UC Berkeley. In 2018, the company completed a $15 million series A round of funding. iota is based in Berkeley, California and is privately held.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 12/31/18 | $15,000,000 | Series A |
Astellas Venture Management Bold Capital Horizons Ventures Ironfire Capital Shanda Group | undisclosed |
